Environmental Endocrine Modulators and Human Health: An Assessment of the Biological Evidence

Abstract

Recently, a great deal of attention and interest has been directed toward the hypothesis that exposure, particularly in utero exposure, to certain environmental chemicals might be capable of causing a spectrum of adverse effects as a result of endocrine modulation. In particular, the hypothesis has focused on the idea that certain organochlorine and other compounds acting as weak estrogens have the capability, either alone or in combination, to produce a variety of adverse effects, including breast, testicular and prostate cancer, adverse effects on male reproductive tract, endometriosis, fertility problems, alterations of sexual behavior, learning disability or delay, and adverse effects on immune and thyroid function. While hormones are potent modulators of biochemical and physiological function, the implication that exposure to environmental hormones (e.g., xenoestrogens) has this capability is uncertain. While it is reasonable to hypothesize that exposure to estrogen-like compounds, whatever their source, could adversely affect human health, biological plausibility alone is an insufficient basis for concluding that environmental endocrine modulators have adversely affected humans. Diethylstilbestrol (DES) is a potent, synthetic estrogen administered under a variety of dosing protocols to millions of women in the belief (now known to be mistaken) that it would prevent miscarriage. As a result of this use, substantial in utero exposure to large numbers of male and female offspring occurred. Numerous studies have been conducted on the health consequences of in utero DES exposure among the adult offspring of these women. There are also extensive animal data on the effects of DES and there is a high degree of concordance between effects observed in animals and humans. The extensive human data in DES-exposed cohorts provide a useful basis for assessing the biological plausibility that potential adverse effects might occur following in utero exposure to compounds identified as environmental estrogens. The effects observed in both animals and humans following in utero exposure to sufficient doses of DES are consistent with basic principles of dose response as well as the possibility of maternal dose levels below which potential non-cancer effects may not occur. Significant differences in estrogenic potency between DES and chemicals identified to date as environmental estrogens, as well as an even larger number of naturally occurring dietary phytoestrogens, must be taken into account when inferring potential effects from in utero exposure to any of these substances. The antiestrogenic properties of many of these same exogenous compounds might also diminish net estrogenic effects. Based on the extensive data on DES-exposed cohorts, it appears unlikely that in utero exposure to usual levels of environmental estrogenic substances, from whatever source, would be sufficient to produce many of the effects (i.e., endometriosis, adverse effects on the male reproductive tract, male and female fertility problems, alterations of...

Increase in plasma pollutant levels in response to weight loss in humans is related to in vitro subcutaneous adipocyte basal lipolysis

“…8 As recently suggested by our group, 9 the increased plasma OC concentrations of reduced-obese individuals raise concern about a potentially harmful side effect of weight loss since several pollutants can act as hormone disrupters. 2,5 The clinical significance of the weight lossinduced plasma pollutants levels observed in the present study is, however, as yet unknown. On the one hand, the effect could be negligible since reduced-obese subjects of the present study show several times less body burden than that reported in Inuit adults, 21 a population that does not present any greater level of metabolic disease than the Southern Québec population.…”

“…Consequently, although the use of these substances has been banned or restricted in Western countries, they are still found in virtually every person on the planet and might cause adverse effects in humans. 2,5 Since pollutants are stored in fat, it has been postulated that adipose tissue loss could result in increased organ and blood concentrations of these compounds. 6 A previous study has confirmed this hypothesis by reporting increased dichlorodiphenyl trichloroethane (DDT)-related compounds concentrations in blood, adipose tissue, heart, lung, spleen and brain in starved mice which were a priori treated with a load of 14 C-DDT.…”

Effect of some phytoestrogens on metabolism of rat adipocytes

“…The exposure to these compounds can adversely affect some physiological functions. It was observed that they are able to cause hyperestrogenic effects including uterine enlargement in immature animals, estrus cycle abnormalities and fertility problems [4]. Phytoestrogens were also found to participate in other events, e.g.…”

Measurement of estrogenic activity in sediments from Haihe and Dagu River, China

“…And they are suspected of being responsible for an increase in the disruption of the normal physiological functions of the endocrine systems of mammals, fish, birds, reptiles and invertebrates (Golden et al, 1998;Tyler et al, 1998). These chemicals include: natural estrogens, such as 17β-estradiol and estrone; synthetic estrogens, such as 17α-ethinylestradiol; as well as xeno-estrogens, such as alkylphenols (including nonylphenol and octylphenol) and Bisphenol A (Gray and Metcalfe, 1997;Staples et al, 1998;Hasselberg et al, 2004;Balch and Metcalfe, 2006).…”